|
NKAP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.15229999997757E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.39710000005111E-06 |
| Normal-vs-Stage2 |
6.841000E-03 |
| Normal-vs-Stage3 |
7.33110000039616E-07 |
| Normal-vs-Stage4 |
1.22049999995433E-06 |
| Stage1-vs-Stage2 |
3.670200E-01 |
| Stage1-vs-Stage3 |
2.947600E-01 |
| Stage1-vs-Stage4 |
3.354800E-01 |
| Stage2-vs-Stage3 |
1.440030E-01 |
| Stage2-vs-Stage4 |
1.479580E-01 |
| Stage3-vs-Stage4 |
8.912000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.48090000554546E-08 |
| Normal-vs-AfricanAmerican |
3.242900E-03 |
| Normal-vs-Asian |
3.777200E-03 |
| Caucasian-vs-AfricanAmerican |
6.430800E-01 |
| Caucasian-vs-Asian |
1.471210E-01 |
| AfricanAmerican-vs-Asian |
5.480000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.65079999950402E-07 |
| Normal-vs-Female |
2.59010000003279E-06 |
| Male-vs-Female |
1.591360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.66810000000029E-05 |
| Normal-vs-Age(41-60Yrs) |
4.31579999959908E-07 |
| Normal-vs-Age(61-80Yrs) |
4.59589999945997E-07 |
| Normal-vs-Age(81-100Yrs) |
7.849800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.357000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.225960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.468600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.766600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.830400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.807600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.076800E-01 |
| Classical-VS-Follicular |
2.396400E-02 |
| Classical-VS-Other |
8.284000E-01 |
| Classical-VS-Normal |
4.01800000000563E-05 |
| Tall-VS-Follicular |
6.674200E-01 |
| Tall-VS-Other |
6.839800E-01 |
| Tall-VS-Normal |
7.58020000000137E-05 |
| Follicular-VS-Other |
5.942000E-01 |
| Follicular-VS-Normal |
4.16110000012182E-07 |
| Other-VS-Normal |
6.544200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.69610000278331E-08 |
| Normal-vs-N1 |
6.73319999755506E-08 |
| N0-vs-N1 |
2.024600E-01 |
|
|
